PL379625A1 - Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli - Google Patents

Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli

Info

Publication number
PL379625A1
PL379625A1 PL379625A PL37962504A PL379625A1 PL 379625 A1 PL379625 A1 PL 379625A1 PL 379625 A PL379625 A PL 379625A PL 37962504 A PL37962504 A PL 37962504A PL 379625 A1 PL379625 A1 PL 379625A1
Authority
PL
Poland
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
novel method
Prior art date
Application number
PL379625A
Other languages
English (en)
Other versions
PL211802B1 (pl
Inventor
Claude Fugier
Thierry Dubuffet
Pascal Langlois
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL379625A1 publication Critical patent/PL379625A1/pl
Publication of PL211802B1 publication Critical patent/PL211802B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL379625A 2003-07-31 2004-07-29 Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy PL211802B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291930A EP1367062B1 (fr) 2003-07-31 2003-07-31 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
PL379625A1 true PL379625A1 (pl) 2006-10-30
PL211802B1 PL211802B1 (pl) 2012-06-29

Family

ID=29414889

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379625A PL211802B1 (pl) 2003-07-31 2004-07-29 Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy

Country Status (20)

Country Link
US (1) US7368580B2 (pl)
EP (1) EP1367062B1 (pl)
JP (1) JP4263744B2 (pl)
CN (1) CN100439392C (pl)
AR (1) AR045150A1 (pl)
AT (1) ATE338058T1 (pl)
AU (1) AU2004261440B2 (pl)
CY (1) CY1105789T1 (pl)
DE (1) DE60307925T2 (pl)
DK (1) DK1367062T3 (pl)
EA (1) EA008644B1 (pl)
ES (1) ES2271497T3 (pl)
HK (1) HK1096407A1 (pl)
MY (1) MY139098A (pl)
NZ (1) NZ544880A (pl)
PL (1) PL211802B1 (pl)
PT (1) PT1367062E (pl)
SI (1) SI1367062T1 (pl)
WO (1) WO2005012328A2 (pl)
ZA (1) ZA200600480B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604144A1 (es) * 1984-11-21 1986-01-16 Farmhispania Procedimiento para la obtencion del acido (2s, 3as, 7as)-1-((s)-1-etoxicarbonil-3-fenilpropil) alanil) exahidro-2-indolincarboxilico
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
SI1321471T1 (pl) * 2003-03-12 2005-08-31 Servier Lab
SI1319668T1 (en) * 2003-03-12 2005-02-28 Les Laboratoires Servier Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril

Also Published As

Publication number Publication date
WO2005012328A3 (fr) 2005-03-24
US20060189813A1 (en) 2006-08-24
US7368580B2 (en) 2008-05-06
EA008644B1 (ru) 2007-06-29
CN1826351A (zh) 2006-08-30
AU2004261440A1 (en) 2005-02-10
ATE338058T1 (de) 2006-09-15
DE60307925D1 (de) 2006-10-12
HK1096407A1 (en) 2007-06-01
PL211802B1 (pl) 2012-06-29
SI1367062T1 (sl) 2006-12-31
PT1367062E (pt) 2006-12-29
NZ544880A (en) 2009-03-31
ZA200600480B (en) 2007-05-30
CN100439392C (zh) 2008-12-03
AU2004261440B2 (en) 2008-07-31
EP1367062B1 (fr) 2006-08-30
DE60307925T2 (de) 2007-05-24
EP1367062A1 (fr) 2003-12-03
WO2005012328A2 (fr) 2005-02-10
JP4263744B2 (ja) 2009-05-13
CY1105789T1 (el) 2011-02-02
MY139098A (en) 2009-08-28
ES2271497T3 (es) 2007-04-16
DK1367062T3 (da) 2007-01-02
JP2006528653A (ja) 2006-12-21
AR045150A1 (es) 2005-10-19
EA200600249A1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
AU4847001A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
AU2001248470A1 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
SI1371659T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
HK1086281A1 (en) Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096406A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
SI1422236T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1268424T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli